MaxCyte, Inc.

    Jurisdiction
    United States
    LEI
    54930053YHXULRFCU991
    ISIN
    US57777K1060 (MXCT)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_flat 49 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €30.69M
    Gross margin
    76.8%
    EBIT
    -€45.02M
    EBIT margin
    -146.7%
    Net income
    -€38.43M
    Net margin
    -125.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €35.85M +16.8% -€36.19M -5.8%
    €42.71M +19.1% -€30.56M -15.6%
    €55.63M +30.3% -€19.14M -37.4%

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Brooke William W N/A +50K $1.29 +$64.50K
    DOUGLAS RICHARD N/A +80K $1.39 +$111.20K
    Erck Stanley C N/A +100K $1.37 +$137.00K
    Masoud Maher President and CEO +75K $1.37 +$102.75K
    Swirsky Douglas J CHIEF FINANCIAL OFFICER +50K $1.29 +$64.50K

    Earnings Calls

    Latest earnings call: May 11, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 368K $1.00M +87K Buy

    Add to watchlist

    Notifications